104 related articles for article (PubMed ID: 15624758)
21. Atypical teratoid/rhabdoid tumors of the central nervous system.
Reddy AT
J Neurooncol; 2005 Dec; 75(3):309-13. PubMed ID: 16195799
[TBL] [Abstract][Full Text] [Related]
22. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells.
Bouvier C; Bartoli C; Aguirre-Cruz L; Virard I; Colin C; Fernandez C; Gouvernet J; Figarella-Branger D
J Neurosurg; 2003 Aug; 99(2):344-50. PubMed ID: 12924709
[TBL] [Abstract][Full Text] [Related]
23. Molecular biomarkers in pediatric glial tumors: a needed wind of change.
Fontebasso AM; Bechet D; Jabado N
Curr Opin Oncol; 2013 Nov; 25(6):665-73. PubMed ID: 24097106
[TBL] [Abstract][Full Text] [Related]
24. Impact of genetic targets on primary brain tumor therapy: what's ready for prime time?
Zalatimo O; Zoccoli CM; Patel A; Weston CL; Glantz M
Adv Exp Med Biol; 2013; 779():267-89. PubMed ID: 23288644
[TBL] [Abstract][Full Text] [Related]
25. Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.
Kagawa N; Maruno M; Suzuki T; Hashiba T; Hashimoto N; Izumoto S; Yoshimine T
Brain Tumor Pathol; 2006 Apr; 23(1):41-7. PubMed ID: 18095118
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of chromosome 1q gain in intracranial ependymomas.
Rajeshwari M; Sharma MC; Kakkar A; Nambirajan A; Suri V; Sarkar C; Singh M; Saran RK; Gupta RK
J Neurooncol; 2016 Apr; 127(2):271-8. PubMed ID: 26725097
[TBL] [Abstract][Full Text] [Related]
27. Advances in the biology and treatment of pediatric central nervous system tumors.
Vitanza NA; Cho YJ
Curr Opin Pediatr; 2016 Feb; 28(1):34-9. PubMed ID: 26709691
[TBL] [Abstract][Full Text] [Related]
28. Implications of prognostic markers in brain tumors.
Grzybicki DM; Moore SA
Clin Lab Med; 1999 Dec; 19(4):833-47. PubMed ID: 10572718
[TBL] [Abstract][Full Text] [Related]
29. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
Lang FF; Miller DC; Koslow M; Newcomb EW
J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
[TBL] [Abstract][Full Text] [Related]
30. Molecular genetic parameters in pathogenesis and prognosis of testicular germ cell tumors.
Heidenreich A; Srivastava S; Moul JW; Hofmann R
Eur Urol; 2000 Feb; 37(2):121-35. PubMed ID: 10705188
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome.
Scheurlen WG; Schwabe GC; Joos S; Mollenhauer J; Sörensen N; Kühl J
J Clin Oncol; 1998 Jul; 16(7):2478-85. PubMed ID: 9667267
[TBL] [Abstract][Full Text] [Related]
32. ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease.
Gilbertson RJ; Bentley L; Hernan R; Junttila TT; Frank AJ; Haapasalo H; Connelly M; Wetmore C; Curran T; Elenius K; Ellison DW
Clin Cancer Res; 2002 Oct; 8(10):3054-64. PubMed ID: 12374672
[TBL] [Abstract][Full Text] [Related]
33. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
Gajjar A; Hernan R; Kocak M; Fuller C; Lee Y; McKinnon PJ; Wallace D; Lau C; Chintagumpala M; Ashley DM; Kellie SJ; Kun L; Gilbertson RJ
J Clin Oncol; 2004 Mar; 22(6):984-93. PubMed ID: 14970185
[TBL] [Abstract][Full Text] [Related]
34. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.
Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA
J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
[TBL] [Abstract][Full Text] [Related]
36. Genetics, prognosis and therapy of central nervous system tumors.
Watkins D; Rouleau GA
Cancer Detect Prev; 1994; 18(2):139-44. PubMed ID: 8025896
[TBL] [Abstract][Full Text] [Related]
37. Microsatellite instability occurs in distinct subtypes of pediatric but not adult central nervous system tumors.
Alonso M; Hamelin R; Kim M; Porwancher K; Sung T; Parhar P; Miller DC; Newcomb EW
Cancer Res; 2001 Mar; 61(5):2124-8. PubMed ID: 11280776
[TBL] [Abstract][Full Text] [Related]
38. Pediatric Ependymoma.
Vitanza NA; Partap S
J Child Neurol; 2016 Oct; 31(12):1354-66. PubMed ID: 26503805
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer.
Sanz-Ortega J; Steinberg SM; Moro E; Saez M; Lopez JA; Sierra E; Sanz-Esponera J; Merino MJ
Histol Histopathol; 2000 Apr; 15(2):455-62. PubMed ID: 10809364
[TBL] [Abstract][Full Text] [Related]
40. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
